A growing number of Indian couples are using GLP-1 injections like Ozempic and Mounjaro for rapid weight loss before their weddings, driven by societal pressure and social media expectations. Medical professionals express concern over misuse, potential counterfeits, and health risks.
A growing number of individuals are using GLP-1 injections like Ozempic and Mounjaro for rapid weight loss to meet conventional beauty standards for weddings, rather than for genuine health concerns. This trend alarms medical professionals due to potential health risks, counterfeit drugs, and unsustainable results.
Canada has become the first G7 nation to approve generic semaglutide injections, making GLP-1 drugs more accessible and affordable. This move by Novo Nordisk follows similar approvals in India and has already led to price reductions for brand-name medications.
Canada has become the first G7 nation to approve generic semaglutide injections, making GLP-1 drugs more accessible and affordable. This move by Novo Nordisk follows similar approvals in India and may pressure US prices, though generics are not expected there until 2032.
A new daily pill, orforglipron, has shown to help maintain weight loss in patients who stopped using GLP-1 injections, with 70% of weight loss retained over a year in trials.
